|
Hope for Alzheimer’s Disease Hope. Esperanza. 希望. Speranza. No matter what language you speak, hope is more than a word, hope is a powerful emotion. Hope is the emotion behind the idea that there is a light at the end of the tunnel and that tomorrow is another day. And as we end this year (2024), we now have hope in the form of a new and promising treatment. But this time not just a treatment for those living with Alzheimer’s disease, but for the first time, a treatment for Alzheimer’s Disease itself. So what does that really mean?
Let's first talk about treatments. Treatments can come in three different forms:
- Treatments that treat our symptoms and help us feel better, for example taking Tylenol for our aches and pains
- Treatments that change the course of our diseases, for example taking a statin (i.e. atorvastatin) to lower cholesterol
- Treatments that cure diseases, for example having surgery when we have an appendicitis
Until now, there have only been medications to treat the symptoms of Alzheimer’s. Until now…
Until now, we had medications that strived to help people living with Alzheimer’s (and their care partners) have more days with less agitation or improved thinking and memory. Until now, we just had medications to help people living with Alzheimer's (and their care partners) have a better night’s sleep.
But now, thanks to two groundbreaking medications that treat Alzheimer’s Disease (Donanemab and Lecanemab), we have hope. I'll call them "Dmab & Lmab" for short. Scientists have known for some time that Alzheimer’s Disease is associated with a buildup of a toxic protein called amyloid in the brain. These amyloid proteins form plaques that ultimately cause brain cell death and contribute to the progressive memory loss, impaired thinking, and difficulty with daily functioning experienced by individuals living with Alzheimer's disease. These new drugs work by helping our immune systems recognize, locate and eliminate toxic proteins, directly targeting Alzheimer's disease with in our brain. Although not a cure, Dmab & Lmab have been found to slow the progression of disease in patients with early stage Alzheimer’s disease.
But the key word here is early. And the earlier the better. As healthcare providers, we understand that studies consistently show greater benefits with earlier treatment.
But the best reason to consider Dmab & Lmab is for those of who us who have or walk side-by-side with someone living with Alzheimer’s disease.
Even though we do not yet know if these drugs will help those living with Alzheimer’s disease live longer, we do know that when given early on in the disease, they may help our loved ones live better. For those of us who believe that it’s not about adding years to your life, but it is about adding life to your years, Dmab & Lmab give us valuable quality time. Early intervention for the treatment of Alzheimer’s helps preserve who we are: the 7 million of us who are husbands, wives, parents, grandparents and friends living with Alzheimer’s disease before the disease changes not only our brain, but changes us.
These drugs give us hope. Hope for those with early-stage Alzheimer’s so that they remain in the early stages longer. Hope for more quality time together, hope for more memories, hope for more of the better days that define who we are.
So as we end 2024, let us continue hope. Let us hope for a future when we not only have medications that treat symptoms and slow progression, but let us now hope for our final step, the one which ends Alzheimer’s Disease forever. Let us hope for THE cure. Here's to a happy and hopeful new year. |